The demand for point of care testing (POCT) is increasing across the globe because of the growing aging population, rising prevalence of chronic diseases, and lifestyle changes. POCT is the performance of a test nearby to the site of the patient care for providing immediate results outside the traditional laboratory environment. In addition to this, diagnostic companies, such as Alere, Abaxis, and Cepheid, have started recognizing the potential of quick molecular diagnostic testing, which why they have launched various point of care products that are based on microfluidic technology in the past few years. This, in turn, is expected to drive the requirement for microfluidic devices.

Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/microfluidic-devic...

Microfluidic devices are gaining traction because they have the ability to perform several of the current large-scale applications at a smaller scale, due to which instrument size and sample consumption can be reduced significantly. As per a research conducted by P&S Intelligence, the global microfluidic devices market is expected to reach a value of $6.4 billion, growing with a 23.0% CAGR, in the near future. The different materials that are utilized for manufacturing these devices include polymer, silicon, and glass. Among these, the largest demand was created for polymer for the manufacturing of microfluidic devices during 2011–2014 and the situation is going to be the same in the coming years as well.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=microflui...

One of the key driving factors of the microfluidic devices market is the growing demand for these devices in genomics and proteomics studies. Microfluidic devices are becoming more and more significant for various biological and chemical analyses. These devices have the ability to manipulate bio particles, including DNA, molecules, and cells, at a very micro level. Some of the advantages of these devices for genomics include reduced reagent consumption, improved test speed, and decreased size of devices, which makes the process efficient than other traditional methods. These factors are expected to result in increased requirement for microfluidic devices.